News

Think Gender, Chronic Bronchitis in COPD


 

EXPERT ANALYSIS FROM A MEETING ON ALLERGY AND RESPIRATORY DISEASES

To drive home the point, Dr. Make showed a slide depicting a rail-thin old man with emphysema alongside the rosy-cheeked model Christy Turlington, who revealed at age 31 that she had early-stage emphysema after maintaining a pack-a-day cigarette habit for nearly a decade.

Dr. Make reported having served as an advisory board member, speaker, or trial investigator for AstraZeneca, Boehringer-Ingelheim, Breathe, Forest, GlaxoSmithKline, Ikaria, MedImmune, Merck, Novartis, Pfizer, and Sunovion, as well as the National Heart, Lung, and Blood Institute.

Barry J. Make

Pages

Recommended Reading

Anticipate Mycobacterial Lung Disease in Anti-TNF Users
MDedge Internal Medicine
ARDS Outcome Linked to Oxygenation at 48 Hours
MDedge Internal Medicine
Prophylactic Semuloparin Cuts Rate of VTE in Cancer Patients
MDedge Internal Medicine
Extended-Release Gabapentin an Option for Augmentation in RLS
MDedge Internal Medicine
PCV13 Works Best Against Pneumococcal Disease in Adults
MDedge Internal Medicine
Early Strides Made in Personalized Refractory Asthma Care
MDedge Internal Medicine
Quality of Dyspnea Directs Diagnosis, Management
MDedge Internal Medicine
FDA Questions CV Events Seen in COPD Drug Trials
MDedge Internal Medicine
Pertussis Immunization Recommended for Adults 65 and Older
MDedge Internal Medicine
Alternative to CPAP Arises for Uncomplicated Sleep Apnea
MDedge Internal Medicine